* Mylan offering 145 SEK/share for Sweden's Meda * Meda rebuffed an approach earlier this month * Shares rose 10 pct before trading halt
(Adds background on healthcare M&A) By Soyoung Kim and Niklas Pollard NEW YORK/STOCKHOLM, April 25 (Reuters) - U.S. generic
drugmaker
(Adds details on GSK drug) LONDON, April 25 (Reuters) - GlaxoSmithKline's
melanoma drug Mekinist - one of several drugs being sold to
Novartis under an asset swap deal - has been
recommended for approval by European regulators. The European Medicines Agency (EMA) said on Friday its
e
LONDON, April 25 (Reuters) - European regulators said on
Friday they had recommended approval of GlaxoSmithKline's
melanoma drug Mekinist and also endorsed wider use of
Bayer's Nexavar as a treatment for thyroid cancer. Mekinist is one of several drugs being sold to Novartis
under an asse
By William James CAMBRIDGE, England, April 25 (Reuters) - Talk of a $100
billion bid by U.S. drugmaker Pfizer for its British
rival AstraZeneca is "a commercial matter between the
companies", Britain's finance minister George Osborne said on
Friday. Shares in Britain's second biggest
LONDON (Alliance News) - Lombard Medical Technology PLC Friday announced it has suspended trading on AIM, after it raised USD55 million in its initial public offering on the NASDAQ market in New York. The company's shares will be cancelled from the AIM market next Wednesday, when it will b
LONDON (Alliance News) - Botox maker Allergan Inc approached Ireland-based pharmaceutical firm Shire PLC about a possible takeover in recent months, but was rebuffed, Reuters reported late Thursday citing people familiar with the matter. The approach did not progress to serious discussions
(Removes paragraph on QVA149, which refers to Ultibro
Breezhaler not Onbrez Breezhaler) ZURICH, April 25 (Reuters) - Patients taking Novartis'
inhaled medicine Onbrez Breezhaler for chronic lung
disease had benefits similar to those taking GlaxoSmithKline's
Seretide, the Swiss drugmaker s
By Adam Jourdan SHANGHAI, April 25 (Reuters) - British drugmaker
GlaxoSmithKline Plc has appointed two executives to new
roles overseeing sales and marketing in China after authorities
accused the firm of corruption last year, a person with direct
knowledge of the decision told Reuters.
LONDON (Alliance News) - AstraZeneca shares jumped Thursday after the pharmaceutical giant maintained its full-year guidance for 2014, even as its pretax profit dropped in the first quarter to end-March, hit by write-downs on the sale of its Alderley Park site and its acquisit
Last checked at 
